Efficacy of Ursodeoxycholic Acid for Japanese Patients With Autoimmune Hepatitis

Hepatology International - India
doi 10.1007/s12072-009-9155-9
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinicolaboratory Characteristics of Japanese Patients With Primary Biliary Cirrhosis-Autoimmune Hepatitis Overlap

Fukushima Journal of Medical Sciences
Medicine
2006English

Clinical Efficacy of Ursodeoxycholic Acid in the Comprehensive Treatment of Patients With Obesity and Gastroesophageal Reflux Disease

GASTROENTEROLOGY
2018English

Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-Line Therapy for Patients With Autoimmune Hepatitis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Enhanced Th17 Responses in Patients With Autoimmune Hepatitis

Middle East Journal of Digestive Diseases
HepatologyGastroenterology
2019English

Background of Effective and Non-Effective Patients With Chronic Hepatitis C Treated With Ursodeoxycholic Acid Who Are Non-Responders to Interferon Therapy.

Acta Hepatologica Japonica
Hepatology
1997English

Influence of Ursodeoxycholic Acid on Insulin Resistance in Patients With Metabolic Syndrome

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2018English

Measurment of Serum Isoursodeoxycholic Acid in Patients During Ursodeoxycholic Acid Treatment.

Acta Hepatologica Japonica
Hepatology
1995English

Anti-Phosphoenolpyruvate Carboxykinase 2 Antibody in Patients With Autoimmune Hepatitis

Hepatology Research
HepatologyInfectious Diseases
2014English

Pgi33 - Ursodeoxycholic Acid to Gallstone Dissolution Therapy in Asymptomatic Cholelithiasis Patients: A Systematic Review of the Efficacy and Safety

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy